Corporate Banner
Satellite Banner
Technology Networks Header
Friday, May 24, 2013
Technology Networks
 
Register | Sign in
Home Page
  News
Return to the previous page

Roswell Park Cancer Institute Purchases Six Ion Torrent Sequencers

Published: Thursday, February 21, 2013
Last Updated: Thursday, February 21, 2013
Bookmark and Share
Life Technologies Corporation announced that the new Center for Personalized Medicine at Roswell Park Cancer Institute has purchased four Ion Proton™ sequencers and two Ion Personal Genome Machine™ sequencers.

Full access to this article is for registered users only.
Registration is free-of-charge and allows access to all content on our web communities.

Already registered? Then please log in at the top of the page.


Scientific News
Biomarkers Found for Major Depressive Disorder
New research highlights biological and genetic markers associated with improved response to adjunctive L-Methylfolate in management of depression.
Biomarkers Discovered for Inflammatory Bowel Disease
Researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and intervention.
Your Immune System: On Surveillance in the War Against Cancer
Wake Forest Baptist Research looks at gene expression profiling in breast cancer.
Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
Assistant Professor at Northwestern Recognized for Cancer Diagnostics Research.
Gene Discoveries Give Hope Against 'Brittle Bone' Disease
Scientists pinpoint mutation that appears to cause severe forms of bone loss.
Two MIT Professors Named Howard Hughes Medical Institute Investigators
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.
microRNA Cooperation Mutes Breast Cancer Oncogenes
Turning up a few microRNAs a little may offer as much anti-breast-cancer activity as turning up one microRNA a lot – and without the unwanted side effects.
NYSCF Scientists Create Personalized Bone Substitutes from Skin Cells
For treatment of large bone defects and traumatic injuries.
Unusual Comparison Nets New Sleep Loss Marker
Paul Shaw, PhD, a researcher at Washington University School of Medicine in St. Louis, uses what he learns in fruit flies to look for markers of sleep loss in humans.
Lucigen Corporation and Research Corporation Technologies Announce Partnership
Partnership to commercialize and distribute the CleanColi™ Expression System, the first Escherichia coli (E. coli)-based recombinant system that lacks unwanted endotoxin.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net